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At the end of ICU stay, success was present in 51 pts (71.8%). Median stay
in the ICU after levosimendan administration was 4 [IQR:1-9] days. A beta-
blocker and an ACE inhibitor were given in 43.1% and 74.5% respectively.
No clinical, biological or hemodynamic characteristics were predictive of
failure to wean from inotropes with levosimendan. Overall, 13 pts (18%) died
in the ICU and another 12 (17%) died after leaving the ICU during their hos-
pital stay. Heart transplantation was performed in 16 patients within 6 months,
13 of them were in the success group. Failure to wean from inotropes within
48 hours of levosimendan administration was a strong predictor of in-hospital
mortality (64% vs 27%; p=0.01).
Conclusions: In patients with advanced heart failure and dependant on
dobutamine or milrinone, levosimendan is a valuable therapeutic option to
wean these patients off intravenous inotropic support.
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Objectives: We sought to evaluate the impact of post-primary percuta-
neous coronary intervention (PCI) patent artery in the infarct-related artery in
patients with ST-segment elevation myocardial infarction (STEMI) and car-
diogenic shock.
Background: Little is known about predictors of survival in patients with
persistent shock following STEMI despite a patent infarct artery.
Methods: This retrospective monocentric study included consecutive
patients with an early cardiogenic shock complicating STEMI from 2007 to
2010 in our center.
All these patients underwent early PCI: ie up to 36 h from symptoms and
only patients with infarct artery patency defined as final TIMI 3 flow were
included.
Results: Between 2007 and 2010, 832 patients underwent primary PCI for
acute STEMI. We studied specifically a cohort of 84 patients with cardiogenic
shock with post-procedure patent TIMI 3 infarct related artery.
The mean age of the patients was 64±13 years. The delay between STEMI
diagnosis and cardiogenic shock and open infarct related artery were 4.5 hours
and 7 hours respectively.
95% of patients underwent revascularization of the culprit lesion and mul-
tisite PCI was performed in 7% of cases.
After PCI, mechanical ventilation was used in 80% of cases and all patients
needed inotropes drugs. In two cases, a percutaneous ECMO support was
decided.
The in-hospital mortality rate was 44 %. In univariate analysis, pulmonary
insufficiency characterized by ratio PaO2/FIO2 (p=0,02), increased serum cre-
atinine (SCr) from baseline-25% (p=0,01) and level of lactates (p<0,01) were
significantly associated with increased in hospital mortality.
In multivariate analysis, the ratio PaO2/FIO2 and an increased SCr were
independent predictors of in hospital mortality.
At 6 months, the mortality rate was 46%. We noted a coronary revascular-
ization in 6 cases, a implantable cardioverter-defibrillator in 3 cases and a left
ventricular ejection fraction –35% in 20 % of patients.
Conclusion: These prognostic variables may be useful for risk-stratification
and in selecting patients for investigation of additional therapies
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Introduction: Massive pulmonary embolism is defined as occlusion of
more than 50% of the pulmonary vasculature or occlusion of two or more
lobar arteries.
Purpose of work: Describe the clinical features, paraclinical findings and
prognosis of patients with massive pulmonary embolism.
Materials and methods: It is a single-center study, retrospective, covering
145 patients hospitalized in the emergency department of the hospital Habib
Thameur in the period from January 2000 to December 2007 with a pulmo-
nary embolism. We divided our patients into 2 groups: one group with a mas-
sive pulmonary embolism (MPG+) and a group without (MPG-).
Results: The diagnosis of massive pulmonary embolism was retained in
23 patients that is 21.3%. no features patient’s specificities (age, sex and
underlying pulmonary defects) were significantly related to massive pulmo-
nary embolism. Clinical examination showed that (MPG+) had a respiratory
rate (RR) and heart rate (HR) significantly higher than the (MPG-) ( average
RR: 27 vs 23, P=0.03) (average HR: 104 vs. 95, P=0.02) .The report PaO2 /
FIO2 was significantly lower in the (MPG+) (304 vs. 358, P=0.02). The trans-
thoracic echocardiography was performed in 42 patients (8: MPG+ and 24:
MPG-), the echocardiographic characteristics which were significantly associ-
ated with massive pulmonary embolism were: right ventricular dilation
(P=0.04) and pulmonary artery hypertention (P=0.0006). Massive pulmonary
embolism was not significantly related to hospital mortality.
Conclusion: Massive pulmonary embolism does not prejudge the outcome
nether clinical consequences nor the prognostic for the patient. 
